250 related articles for article (PubMed ID: 29522947)
1. Are studies of psychotherapies for depression more or less generalizable than studies of antidepressants?
Lorenzo-Luaces L; Zimmerman M; Cuijpers P
J Affect Disord; 2018 Jul; 234():8-13. PubMed ID: 29522947
[TBL] [Abstract][Full Text] [Related]
2. The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20 Years.
Zimmerman M; Holst CG; Clark HL; Multach M; Walsh E; Rosenstein LK; Gazarian D
CNS Drugs; 2016 Dec; 30(12):1209-1218. PubMed ID: 27541608
[TBL] [Abstract][Full Text] [Related]
3. The Generalizability of Randomized Controlled Trials of Self-Guided Internet-Based Cognitive Behavioral Therapy for Depressive Symptoms: Systematic Review and Meta-Regression Analysis.
Lorenzo-Luaces L; Johns E; Keefe JR
J Med Internet Res; 2018 Nov; 20(11):e10113. PubMed ID: 30413400
[TBL] [Abstract][Full Text] [Related]
4. Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice.
van der Lem R; van der Wee NJ; van Veen T; Zitman FG
Psychother Psychosom; 2012; 81(4):226-34. PubMed ID: 22584117
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
[TBL] [Abstract][Full Text] [Related]
6. The Sequential Integration of Pharmacotherapy and Psychotherapy in the Treatment of Major Depressive Disorder: A Meta-Analysis of the Sequential Model and a Critical Review of the Literature.
Guidi J; Tomba E; Fava GA
Am J Psychiatry; 2016 Feb; 173(2):128-37. PubMed ID: 26481173
[TBL] [Abstract][Full Text] [Related]
7. Psychotherapy, antidepressants, and their combination for chronic major depressive disorder: a systematic review.
Spijker J; van Straten A; Bockting CL; Meeuwissen JA; van Balkom AJ
Can J Psychiatry; 2013 Jul; 58(7):386-92. PubMed ID: 23870720
[TBL] [Abstract][Full Text] [Related]
8. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication.
Parikh SV; Segal ZV; Grigoriadis S; Ravindran AV; Kennedy SH; Lam RW; Patten SB;
J Affect Disord; 2009 Oct; 117 Suppl 1():S15-25. PubMed ID: 19682749
[TBL] [Abstract][Full Text] [Related]
9. Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants.
Freeman MP; Mischoulon D; Tedeschini E; Goodness T; Cohen LS; Fava M; Papakostas GI
J Clin Psychiatry; 2010 Jun; 71(6):682-8. PubMed ID: 20573327
[TBL] [Abstract][Full Text] [Related]
10. The generalizability of psychotherapy efficacy trials in major depressive disorder: an analysis of the influence of patient selection in efficacy trials on symptom outcome in daily practice.
van der Lem R; de Wever WW; van der Wee NJ; van Veen T; Cuijpers P; Zitman FG
BMC Psychiatry; 2012 Nov; 12():192. PubMed ID: 23137143
[TBL] [Abstract][Full Text] [Related]
11. Telephone-administered psychotherapy in combination with antidepressant medication for the acute treatment of major depressive disorder.
Corruble E; Swartz HA; Bottai T; Vaiva G; Bayle F; Llorca PM; Courtet P; Frank E; Gorwood P
J Affect Disord; 2016 Jan; 190():6-11. PubMed ID: 26480205
[TBL] [Abstract][Full Text] [Related]
12. Differential efficacy of cognitive behavioral therapy and psychodynamic therapy for major depression: a study of prescriptive factors.
Driessen E; Smits N; Dekker JJ; Peen J; Don FJ; Kool S; Westra D; Hendriksen M; Cuijpers P; Van HL
Psychol Med; 2016 Mar; 46(4):731-44. PubMed ID: 26750445
[TBL] [Abstract][Full Text] [Related]
13. Psychotherapy and pharmacotherapy in depression.
Powers RH; Kniesner TJ; Croghan TW
J Ment Health Policy Econ; 2002 Dec; 5(4):153-61. PubMed ID: 14578549
[TBL] [Abstract][Full Text] [Related]
14. Major depressive disorder in breast cancer: a critical systematic review of pharmacological and psychotherapeutic clinical trials.
Carvalho AF; Hyphantis T; Sales PM; Soeiro-de-Souza MG; Macêdo DS; Cha DS; McIntyre RS; Pavlidis N
Cancer Treat Rev; 2014 Apr; 40(3):349-55. PubMed ID: 24084477
[TBL] [Abstract][Full Text] [Related]
15. Inclusion/exclusion criteria in placebo-controlled studies of vortioxetine: Comparison to other antidepressants and implications for product labeling.
Zimmerman M; Clark HL; Multach MD; Walsh E; Rosenstein LK; Gazarian D
J Affect Disord; 2016 Jan; 190():357-361. PubMed ID: 26546771
[TBL] [Abstract][Full Text] [Related]
16. Treatment of depression in cardiovascular disease.
Mavrides N; Nemeroff C
Depress Anxiety; 2013 Apr; 30(4):328-41. PubMed ID: 23293051
[TBL] [Abstract][Full Text] [Related]
17. Improving care for depression in patients with comorbid substance misuse.
Watkins KE; Paddock SM; Zhang L; Wells KB
Am J Psychiatry; 2006 Jan; 163(1):125-32. PubMed ID: 16390899
[TBL] [Abstract][Full Text] [Related]
18. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials.
Iovieno N; Tedeschini E; Ameral VE; Rigatelli M; Papakostas GI
Int Clin Psychopharmacol; 2011 Mar; 26(2):69-74. PubMed ID: 20962663
[TBL] [Abstract][Full Text] [Related]
19. Have Treatment Studies of Depression Become Even Less Generalizable? Applying the Inclusion and Exclusion Criteria in Placebo-Controlled Antidepressant Efficacy Trials Published over 20 Years to a Clinical Sample.
Zimmerman M; Balling C; Chelminski I; Dalrymple K
Psychother Psychosom; 2019; 88(3):165-170. PubMed ID: 31096246
[TBL] [Abstract][Full Text] [Related]
20. Tachyphylaxis in major depressive disorder: A review of the current state of research.
Kinrys G; Gold AK; Pisano VD; Freeman MP; Papakostas GI; Mischoulon D; Nierenberg AA; Fava M
J Affect Disord; 2019 Feb; 245():488-497. PubMed ID: 30439676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
